Physician profile
Christopher Lars Johnsrude
NPI 1336144401
$23,118.30
in general payments reported to CMS, 2019-2025
10 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $55.93 · 2022: $104 · 2023: $20.99 · 2024: $7,833 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,500.00 |
| Food and Beverage | $340.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $14,058.77 | 2019-2025 | Carto 3 |
| Medical Device Business Services, INC. | $8,550.00 | 2024-2025 | Carto 3 |
| Abbott Laboratories | $212.23 | 2021-2025 | Amplatzer Piccolo, Cardiomems, Amplatzer |
| Medtronic Vascular, INC. | $90.55 | 2019 | |
| Boston Scientific Corporation | $62.72 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor, Cds - Mct/Cem Monitoring |
| Siemens Medical Solutions USA, INC. | $56.20 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Medtronic, INC. | $35.19 | 2021-2024 | Invos |
| Baxter Healthcare | $30.72 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| W. L. Gore & Associates, INC. | $15.70 | 2025 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnsrude listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.